134 related articles for article (PubMed ID: 38296352)
21. Deficit of circulating CD19
Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
[TBL] [Abstract][Full Text] [Related]
22. Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy.
Hwang YY; Chan TSY; Chan FHY; Lau CWP; Luk YY; Lau GWN; Chan KP; Leung KH; Kho B; Lau JSM; Lau CK; Mak V; Yip SF; Lin SY; Sim JPY; Kwong YL
Ann Hematol; 2022 Jun; 101(6):1163-1172. PubMed ID: 35412083
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
Jalaeikhoo H; Khajeh-Mehrizi A
PLoS One; 2015; 10(5):e0126925. PubMed ID: 25970182
[TBL] [Abstract][Full Text] [Related]
24. Relationship between plasma rabbit anti-thymocyte globulin concentration and immunosuppressive therapy response in patients with severe aplastic anemia.
Narita A; Muramatsu H; Ichikawa D; Hamada M; Nishikawa E; Suzuki K; Kawashima N; Okuno Y; Nishio N; Hama A; Yamazaki H; Nakao S; Kojima S; Takahashi Y
Eur J Haematol; 2021 Aug; 107(2):255-264. PubMed ID: 33949001
[TBL] [Abstract][Full Text] [Related]
25. [A study of hypoplastic myelodysplastic syndrome].
Sato Y; Mituhashi S; Otani K; Kamoshita M; Hasegawa Y; Ninomiya H; Nagasawa T; Abe T
Rinsho Ketsueki; 1993 Nov; 34(11):1431-7. PubMed ID: 8254904
[TBL] [Abstract][Full Text] [Related]
26. Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation.
Kim SY; Le Rademacher J; Antin JH; Anderlini P; Ayas M; Battiwalla M; Carreras J; Kurtzberg J; Nakamura R; Eapen M; Deeg HJ
Haematologica; 2014 Dec; 99(12):1868-75. PubMed ID: 25107891
[TBL] [Abstract][Full Text] [Related]
27. [Results of immunosupressive therapy in children with severe aplastic anaemia. Report of the Polish Paediatric Haematology Group].
Pawelec K; Matysiak M; Niewiadomska E; Rokicka-Milewska R; Kowalczyk J; Stefaniak J; Balwierz W; Załecka-Czerpko E; Chybicka A; Szmyd K; Sońta-Jakimczyk D; Bubała H; Krauze A; Wysocki M; Kurylak A; Wachowiak J; Grund G; Młynarski W; Bulas M; Krawczuk-Rybak M; Leszczyńska E; Urasiński T; Peregud-Pogorzelski J; Balcerska A; Włazłowski M
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1092-7. PubMed ID: 19531832
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia.
Chen HF; Xu BX; Shen HS; Li ZY; Jin LJ; Tang JQ; Wang J; Zhu JJ; Qin LM; Cui QY; Ren YY; Wu TQ
Drug Des Devel Ther; 2014; 8():1299-305. PubMed ID: 25246771
[TBL] [Abstract][Full Text] [Related]
29. Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.
Anderlini P; Wu J; Gersten I; Ewell M; Tolar J; Antin JH; Adams R; Arai S; Eames G; Horwitz ME; McCarty J; Nakamura R; Pulsipher MA; Rowley S; Leifer E; Carter SL; DiFronzo NL; Horowitz MM; Confer D; Deeg HJ; Eapen M
Lancet Haematol; 2015 Sep; 2(9):e367-75. PubMed ID: 26685770
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT).
de Planque MM; Bacigalupo A; Würsch A; Hows JM; Devergie A; Frickhofen N; Brand A; Nissen C
Br J Haematol; 1989 Sep; 73(1):121-6. PubMed ID: 2803967
[TBL] [Abstract][Full Text] [Related]
31. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
[TBL] [Abstract][Full Text] [Related]
32. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.
Scheinberg P; Nunez O; Wu C; Young NS
Br J Haematol; 2006 Jun; 133(6):606-11. PubMed ID: 16704434
[TBL] [Abstract][Full Text] [Related]
33. The effect of age in patients with acquired aplastic anaemia treated with immunosuppressive therapy: comparison of Adolescents and Young Adults with children and older adults.
Cabannes-Hamy A; Boissel N; Peffault De Latour R; Lengliné E; Leblanc T; de Fontbrune FS; Raffoux E; Robin M; Xhaard A; Baruchel A; Socié G; Dhédin N
Br J Haematol; 2018 Dec; 183(5):766-774. PubMed ID: 30407615
[TBL] [Abstract][Full Text] [Related]
34. Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting.
Hwang YY; Gill H; Chan TSY; Leung GMK; Cheung CYM; Kwong YL
Hematology; 2018 Aug; 23(7):399-404. PubMed ID: 29303047
[TBL] [Abstract][Full Text] [Related]
35. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
Clé DV; Atta EH; Dias DSP; Lima CBL; Bonduel M; Sciuccati G; Medeiros LA; de Oliveira MM; Blum Fonseca PB; Saad STO; Hamerschlak N; Salvino MA; Garanito MP; Pazin-Filho A; Scheinberg P; Calado RT
Ann Hematol; 2018 Nov; 97(11):2039-2046. PubMed ID: 29978284
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology, Clinico-Haematological Profile and Management of Aplastic Anaemia: AIIMS Experience.
Mahapatra M; Singh PK; Agarwal M; Prabhu M; Mishra P; Seth T; Tyagi S; Patil HP; Saxena R
J Assoc Physicians India; 2015 Mar; 63(3 Suppl):30-5. PubMed ID: 26529865
[TBL] [Abstract][Full Text] [Related]
37. Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party.
Bacigalupo A; Chaple M; Hows J; Van Lint MT; McCann S; Milligan D; Chessells J; Goldstone AH; Ottolander J; van't Veer ET
Br J Haematol; 1993 Jan; 83(1):145-51. PubMed ID: 8435323
[TBL] [Abstract][Full Text] [Related]
38. Characterization of bone marrow mesenchymal stromal cells in aplastic anaemia.
Hamzic E; Whiting K; Gordon Smith E; Pettengell R
Br J Haematol; 2015 Jun; 169(6):804-13. PubMed ID: 25819548
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive therapy in adults with aplastic anaemia: single-institution experience from India.
Nair V; Sharma A; Das S; Sondhi V; Sharma S
Postgrad Med J; 2013 Sep; 89(1055):508-15. PubMed ID: 23686628
[TBL] [Abstract][Full Text] [Related]
40. Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - A Swedish nationwide cohort study.
Vaht K; Göransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Brune M; Andersson PO
Eur J Haematol; 2018 Jun; 100(6):613-620. PubMed ID: 29532518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
